4.5 Article

Repetitive TLR3 activation in the lung induces skeletal muscle adaptations and cachexia

Journal

EXPERIMENTAL GERONTOLOGY
Volume 106, Issue -, Pages 88-100

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.exger.2018.02.002

Keywords

Ageing; Mouse models; TLR3; Skeletal muscle; Physical function; COPD cachexia

Funding

  1. NIH: NCATS [TL1TR001440]
  2. NIA [P30 AG024832, R56 AG051267]
  3. NIAID [AI062885]
  4. NIH [UL1TR001439]
  5. NIEHS [T32ES007254, ES006676]
  6. NSF [DMS-1361411/DMS-1361318]
  7. University of Texas Medical Branch: The Sealy Center for Molecular Medicine
  8. Sealy Center for Environmental Health and Medicine
  9. Brown Foundation
  10. Division Of Mathematical Sciences
  11. Direct For Mathematical & Physical Scien [1361411] Funding Source: National Science Foundation

Ask authors/readers for more resources

Due to immunosenescence, older adults are particularly susceptible to lung-based viral infections, with increased severity of symptoms in those with underlying chronic lung disease. Repeated respiratory viral infections produce lung maladaptations, accelerating pulmonary dysfunction. Toll like 3 receptor (TLR3) is a membrane protein that senses exogenous double-stranded RNA to activate the innate immune response to a viral infection. Polyinosinic-polycytidylic acid [poly(I:C)] mimics double stranded RNA and has been shown to activate TLR3. Utilizing an established mouse viral exacerbation model produced by repetitive intranasal poly(I:C) administration, we sought to determine whether repetitive poly(I:C) treatment induced negative muscle adaptations (i.e. atrophy, weakness, and loss of function). We determined skeletal muscle morphological properties (e.g. fiber-type, fiber cross-sectional area, muscle wet mass, etc.) from a treated group ((poly(I:C), n = 9) and a sham-treated control group (PBS, n = 9); age approximately 5 months. In a subset (n = 4 for both groups), we determined in vivo physical function (using grip test for strength, rotarod for overall motor function, and treadmill for endurance) and muscle contractile properties with in vitro physiology (in the EDL, soleus and diaphragm). Our findings demonstrate that poly(I:C)-treated mice exhibit both muscle morphological and functional deficits. Changes of note when comparing poly(I:C)-treated mice to PBS-treated controls include reductions in fiber cross-sectional area (-27% gastrocnemius, -25% soleus, -16% diaphragm), contractile dysfunction (soleus peak tetanic force, -26%), muscle mass (gastrocnemius -19%, soleus -23%), physical function (grip test -34%), body mass (-20%), and altered oxidative capacity (140% increase in succinate dehydrogenase activity in the diaphragm, but 66% lower in the gastrocnemius). Our data is supportive of a new model of cachexia/sarcopenia that has potential for future research into the mechanisms underlying muscle wasting.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available